The North America Sickle Cell Disease Market encompasses the medical treatments, diagnostics, and patient management services for this inherited blood disorder, which is characterized by abnormally shaped red blood cells. SCD leads to chronic anemia, debilitating vaso-occlusive crises (VOCs), and severe organ damage. This market is undergoing a profound transformation driven by the shift from...